Few big biotech firms have been as successful recently as Celgene. The maker of multiple myeloma home run drug Revlimid has seen its shares rocket higher by more than 38% over the last three months ...

Just as governments around the world have spent the past year racing to get the coronavirus pandemic under control, we should be racing to contend with a similarly harmful global event: the threat of ...

But Sequoia is hardly the first concentrated fund to soar, then take a nosedive, due to its heavily weighted positions. Some of the most fabled mutual funds of the past few decades have experienced a ...

The Neos S&P 500(R) High Income ETF offers a 12% annual yield through monthly payouts by selling covered calls on S&P 500 index options. SPYI's active management and use of tax-loss harvesting ...

Preferred stock exists somewhere in the middle between equity and debt. It has some of the disadvantages of both, with very little of the upside. Preferred stock funds have not performed as well as ...

A diversified portfolio can help you manage risk and achieve long-term financial goals by spreading investments across different asset classes. Your diversification strategy will depend on your ...